The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oxenius, A.
Right arrow Articles by Hengartner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oxenius, A.
Right arrow Articles by Hengartner, H.

The Journal of Immunology, Vol 158, Issue 12 5717-5726, Copyright © 1997 by American Association of Immunologists

ARTICLES

Functional in vivo MHC class II loading by endogenously synthesized glycoprotein during viral infection

A Oxenius, MF Bachmann, D Mathis, C Benoist, RM Zinkernagel and H Hengartner
Institute of Experimental Immunology, Department of Pathology, University of Zurich, Switzerland.

MHC class II presentation of antigenic peptides derived from soluble proteins is usually preceded by antigenic uptake via (nonreceptor- mediated) endocytosis by professional APCs, followed by processing in endosomal compartments. Although in vitro alternative pathways for MHC class II loading have been described for certain intracellularly synthesized proteins, the importance of these pathways has not been assessed in vivo. We have shown previously that endogenously produced membrane-associated glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV), a noncytopathic virus, can be presented in vitro on MHC class II molecules in the absence of the invariant chain (Ii), whereas the cytosolic LCMV nucleoprotein (LCMV-NP) failed to be presented under the same conditions. Taking advantage of this system, we analyzed presentation of LCMV-GP and LCMV-NP in vivo in Ii-deficient mice and followed the induced Th cell and B cell responses. At early time points after LCMV infection of li-deficient mice, we found in vivo MHC class II loading exclusively by the endogenously synthesized LCMV-GP, whereas no MHC class II loading by LCMV-NP could be detected. As a direct consequence, LCMV-specific Th cells exhibited initially only LCMV-GP specificity. In contrast, both LCMV-GP- and LCMV-NP-derived epitopes were presented in comparable amounts on APCs upon LCMV infection of normal mice, and LCMV-GP- as well as LCMV-NP-specific Th cells were comparably induced in vivo. Thus, cell internal MHC class II loading pathways are functional in vivo and may become dominant if the usual Ag presentation pathways are hampered.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff
Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes
J. Immunol., December 1, 2006; 177(11): 7588 - 7598.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. P. Longhi, B. Sivasankar, N. Omidvar, B. P. Morgan, and A. Gallimore
Cutting Edge: Murine CD59a Modulates Antiviral CD4+ T Cell Activity in a Complement-Independent Manner
J. Immunol., December 1, 2005; 175(11): 7098 - 7102.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. J. Zaunders, M. L. Munier, D. E. Kaufmann, S. Ip, P. Grey, D. Smith, T. Ramacciotti, D. Quan, R. Finlayson, J. Kaldor, et al.
Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection
Blood, September 1, 2005; 106(5): 1660 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. Hunziker, M. Recher, A. Ciurea, M. M.A. Martinic, B. Odermatt, H. Hengartner, and R. M. Zinkernagel
Antagonistic Variant Virus Prevents Wild-type Virus-induced Lethal Immunopathology
J. Exp. Med., October 21, 2002; 196(8): 1039 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Yasukawa, H. Ohminami, K. Kojima, T. Hato, A. Hasegawa, T. Takahashi, H. Hirai, and S. Fujita
HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4+ T lymphocytes
Blood, September 1, 2001; 98(5): 1498 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. E. Hassett, J. Zhang, and J. L. Whitton
Induction of Antiviral Antibodies by DNA Immunization Requires neither Perforin-Mediated nor CD8+-T-Cell-Mediated Lysis of Antigen-Expressing Cells
J. Virol., September 1, 1999; 73(9): 7870 - 7873.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
G. Kenty and E. K. Bikoff
BALB/c Invariant Chain Mutant Mice Display Relatively Efficient Maturation of CD4+ T Cells in the Periphery and Secondary Proliferative Responses Elicited upon Peptide Challenge
J. Immunol., July 1, 1999; 163(1): 232 - 241.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Yasukawa, H. Ohminami, S. Kaneko, Y. Yakushijin, Y. Nishimura, K. Inokuchi, T. Miyakuni, S. Nakao, K. Kishi, I. Kubonishi, et al.
CD4+ Cytotoxic T-Cell Clones Specific for bcr-abl b3a2 Fusion Peptide Augment Colony Formation by Chronic Myelogenous Leukemia Cells in a b3a2-Specific and HLA-DR-Restricted Manner
Blood, November 1, 1998; 92(9): 3355 - 3361.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1997 by The American Association of Immunologists, Inc. All rights reserved.